Related Experiment Video
Updated: Aug 13, 2026

Performing Colonoscopic-Guided Pinch Biopsies in Mice and Evaluating Subsequent Tissue Changes
Published on: February 5, 2021
Lessons for inflammatory bowel disease from rheumatology
1School of Clinical Science, University of Liverpool, Duncan Building, Daulby Street, Liverpool L69 3GA, UK. rhodesjm@liverpool.ac.uk
Gastroenterology and rheumatology share common ground in chronic inflammatory diseases like inflammatory bowel disease and rheumatoid arthritis. Further research into shared genetic, environmental, and pathogenic mechanisms can illuminate novel treatments.
Area of Science:
- Gastroenterology
- Rheumatology
- Immunology
- Genetics
Background:
- Significant overlap exists between gastroenterology and rheumatology, particularly concerning chronic inflammatory conditions.
- Conditions like inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) share uncertain etiologies, involving genetic and environmental factors, leading to chronic inflammation without clear pathogens.
Purpose of the Study:
- To explore commonalities between gastroenterological and rheumatological diseases beyond drug side effects.
- To identify key research questions at the intersection of these fields, focusing on pathogenesis and treatment.
Main Methods:
- Comparative literature review of gastroenterological and rheumatological research.
- Identification of specific research questions regarding genetic associations (HLA alleles, HLA-B51), environmental factors (smoking), and potential therapeutic targets (etanercept).
Main Results:
- Highlights the need to investigate functional differences in HLA class II alleles associated with RA and ulcerative colitis (UC).
- Examines the differential impact of smoking on Crohn's disease (CD) and RA incidence.
- Questions the role of pANCA in UC pathogenesis and the efficacy of etanercept in UC, given similarities with RA.
Conclusions:
- Emphasizes the potential for cross-disciplinary research to advance understanding of chronic inflammatory diseases.
- Suggests that investigating shared mechanisms, such as NF-kappaB activation and bacterial involvement in cancer development, is crucial for both inflamed colon and joints.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations

